Andrew Hastie’s ‘Economic Nuclear Bomb’: Why Wall Street isn’t buying it just now
Andrew Hastie says Iran has detonated an economic nuclear bomb. Wall Street's reaction so far: a shrug.
Daily News for Informed Investors
Andrew Hastie says Iran has detonated an economic nuclear bomb. Wall Street's reaction so far: a shrug.
Switzer Report leverages Australia's most experienced finance and markets team to provide more in-depth commentary and analysis that can benefit your portfolio. Take a free trial for yourself to find out.
Start Your Free TrialOur stock picking expert says ResMed is a quality business now facing two new headwinds. Here's what it has to overcome.
Andrew Hastie says Iran has detonated an economic nuclear bomb. Wall Street's reaction so far: a shrug.
Telstra customers are being warned about scammers using the telco's outage as bait. Here's what to look out for.
As Pauline Hanson drops back in the polls, we unpack what it means when reading the political tea leaves of power.
As we race to get more people into home ownership, we mustn’t overlook the threat this poses to Australians’ mental health.
It's a stock market showdown. What would our experts buy and what are they avoiding? Find out on this week's episode of The Switzer Show.
Looking at the portfolios of my financial advice clients, which have largely outperformed the broader market over the past 12 months, I’m shifting towards a…
Here are three active listed infrastructure funds to consider and the pick of the ETFs.
Here are two situations that have recently been described as “transformational” where I would be prepared to bet on a positive outcome.
Twelve stocks won an upgrade this week, 17 copped a downgrade. Here’s who moved, why, and what the brokers are watching next.
For our “HOT” stock today, Raymond Chan, Private Client Adviser and Head of Asian Desk explains why Morgans stock of the week is Infratil (IFT).
Here is every stock rated this week on the Switzer Show, in the guests’ own words. Peter Switzer put seven quality names that have come…
While it's quiet on the Australian data front, the US is busy....
Neuren shares fell when Europe knocked back its treatment for a rare...
4DMedical was the ASX’s best-performing healthcare stock through the last financial-year close....
Were things really better in Australia's 'good old days'? A team of...
Our stock picking expert says ResMed is a quality business now facing...
Suburbs with a higher share of owner-occupied homes recorded significantly stronger long-term...
How exactly has Trump earned so much money from cryptocurrency?
1 July is the day a swag of new rules kick in....
As we race to get more people into home ownership, we mustn’t...
Here are three possible side effects from negative gearing changes which could...
After years of rapid growth, Australia’s housing market is beginning to cool....
Here’s what’s changing, and what to know if you are buying property...
As Pauline Hanson drops back in the polls, we unpack what it...
Opposition leader Angus Taylor has delivered his most comprehensive attack so far...
Despite all the talk since the election about action to boost productivity,...
With Victoria heading to the polls on 28 November, it’s time to...